XML 62 R12.htm IDEA: XBRL DOCUMENT v2.4.1.9
Debt
12 Months Ended
Jan. 31, 2015
Debt Disclosure [Abstract]  
Debt
Debt

Senior notes. Unsecured senior debt, net of unamortized discounts, as of January 31, 2015 and February 1, 2014 consisted of the following:

($000)
 
2014

 
2013

6.38% Series A Senior Notes due 2018
 
$
85,000

 
$
85,000

6.53% Series B Senior Notes due 2021
 
65,000

 
65,000

3.375% Senior Notes due 2024¹
 
248,375

 

Total
 
$
398,375

 
$
150,000

¹Net of unamortized discount of $1.6 million at January 31, 2015.

In September 2014, the Company issued unsecured 3.375% Senior Notes due September 2024 (the “2024 Notes”) with an aggregate principal amount of $250 million at a price equal to 99.329% of the principal amount. Cash proceeds, net of discount and other issuance fees and expenses, were approximately $246 million and were used to purchase the Company’s New York buying office for $222 million and for other general corporate purposes. Interest on the 2024 Notes is payable semi-annually beginning March 2015.

At January 31, 2015, the Company also had outstanding two series of unsecured senior notes in the aggregate principal amount of $150 million, held by various institutional investors. The Series A notes totaling $85 million are due in December 2018 and bear interest at a rate of 6.38%. The Series B notes totaling $65 million are due in December 2021 and bear interest at a rate of 6.53%. Borrowings under these senior notes are subject to certain financial covenants, including interest coverage and other financial ratios. As of January 31, 2015, the Company was in compliance with these covenants.

The 2024 Notes, Series A, and Series B senior notes are all subject to prepayment penalties for early payment of principal.

The aggregate fair value of the three outstanding senior note issuances was approximately $442 million as of January 31, 2015 and the aggregate fair value of the Series A and Series B notes was $182 million as of February 1, 2014. The fair value is estimated by obtaining comparable market quotes which are considered to be Level 1 inputs under the fair value measurements and disclosures guidance.

The following table shows scheduled annual principal payments on Long-term debt:

($000)
 
 
 
 
 
 
 
 
 
 
2015

 
2016

 
2017

 
2018

 
2019

 
Thereafter

$

 
$

 
$

 
$
85,000

 
$

 
$
315,000



The table below shows the components of interest expense and income for fiscal 2014, 2013, and 2012:
($000)
 
2014

 
2013

 
2012

Interest expense on long-term debt
 
$
12,990

 
$
9,721

 
$
9,721

Other interest expense
 
1,230

 
1,350

 
1,665

Capitalized interest
 
(10,825
)
 
(10,799
)
 
(3,851
)
Interest income
 
(411
)
 
(519
)
 
(628
)
Total interest expense (income), net
 
$
2,984

 
$
(247
)
 
$
6,907




Revolving credit facility. The Company's $600 million unsecured revolving credit facility expires in June 2017 and contains a $300 million sublimit for issuance of standby letters of credit. Interest on this facility is based on LIBOR plus an applicable margin (currently 100 basis points) and is payable quarterly and upon maturity. As of January 31, 2015 the Company had no borrowings or standby letters of credit outstanding under this facility and the $600 million credit facility remains in place and available.

The revolving credit facility is subject to certain financial covenants, including interest coverage and other financial ratios. In addition, the interest rates under the revolving credit facility may vary depending on actual interest coverage ratios achieved. As of January 31, 2015, the Company was in compliance with these covenants.
Standby letters of credit and collateral trust. The Company uses standby letters of credit outside of its revolving credit facility in addition to a funded trust to collateralize its insurance obligations. As of January 31, 2015 and February 1, 2014, the Company had $19.5 million and $24.3 million, respectively, in standby letters of credit and $56.3 million and $47.2 million, respectively, in a collateral trust. The standby letters of credit are collateralized by restricted cash and the collateral trust consists of restricted cash, cash equivalents, and investments.
Trade letters of credit. The Company had $32.8 million and $31.6 million in trade letters of credit outstanding at January 31, 2015 and February 1, 2014, respectively.